10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2016 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 9, 2017) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net revenues | $ 177,526 | 153,290 | 139,367 |
| Cost of revenues | 148,669 | 126,762 | 114,000 |
| Gross profit | 28,857 | 26,528 | 25,367 |
| Operating expenses | 18,519 | 17,074 | 16,568 |
| Operating profit | 10,338 | 9,454 | 8,799 |
| Interest expense, net | 1,058 | 838 | 600 |
| Loss on early extinguishment of debt | 643 | 0 | 521 |
| Income before income tax provision | 8,637 | 8,616 | 7,678 |
| Income tax provision | 3,317 | 3,386 | 3,033 |
| Income from continuing operations | 5,320 | 5,230 | 4,645 |
| Income (loss) from discontinued operations, net of tax | (1) | 9 | (1) |
| Net income | 5,319 | 5,239 | 4,644 |
| Net income attributable to noncontrolling interest | (2) | (2) | 0 |
| Net income attributable to CVS Health | 5,317 | 5,237 | 4,644 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 4.93 | 4.65 | 3.98 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.01 | 0.00 |
| Net income attributable to CVS Health (in dollars per share) | 4.93 | 4.66 | 3.98 |
| Weighted average common shares outstanding (in shares) | 1,073 | 1,118 | 1,161 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 4.91 | 4.62 | 3.96 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | 0.01 | 0.00 |
| Net income attributable to CVS Health (in dollars per share) | 4.90 | 4.63 | 3.96 |
| Weighted average common shares outstanding (in shares) | 1,079 | 1,126 | 1,169 |
| Dividends declared per common share (in dollars per share) | 1.70 | 1.40 | 1.10 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2016 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 9, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net income | $ 5,319 | 5,239 | 4,644 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustments, net of tax | 38 | (100) | (35) |
| Net cash flow hedges, net of tax | 2 | 2 | 4 |
| Pension and other postretirement benefits, net of tax | 13 | (43) | (37) |
| Net other comprehensive income (loss) | 53 | (141) | (68) |
| Comprehensive income | 5,372 | 5,098 | 4,576 |
| Comprehensive income attributable to noncontrolling interest | (2) | (2) | 0 |
| Comprehensive income attributable to CVS Health | 5,370 | 5,096 | 4,576 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2016 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 9, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 172,310 | 148,954 | 132,406 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (142,511) | (122,498) | (105,362) |
| Cash paid to other suppliers and employees | (15,550) | (14,162) | (15,344) |
| Interest received | 20 | 21 | 15 |
| Interest paid | (1,140) | (629) | (647) |
| Income taxes paid | (3,060) | (3,274) | (2,931) |
| Net cash provided by operating activities | 10,069 | 8,412 | 8,137 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,224) | (2,367) | (2,136) |
| Proceeds from sale-leaseback transactions | 230 | 411 | 515 |
| Proceeds from sale of property and equipment and other assets | 37 | 35 | 11 |
| Acquisitions (net of cash acquired) and other investments | (539) | (11,475) | (2,439) |
| Purchase of available-for-sale investments | (65) | (267) | (157) |
| Maturity of available-for-sale investments | 91 | 243 | 161 |
| Net cash used in investing activities | (2,470) | (13,420) | (4,045) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 1,874 | (685) | 685 |
| Proceeds from issuance of long-term debt | 3,455 | 14,805 | 1,483 |
| Repayments of long-term debt | (5,943) | (2,902) | (3,100) |
| Purchase of noncontrolling interest in subsidiary | (39) | 0 | 0 |
| Payment of contingent consideration | (26) | (58) | 0 |
| Dividends paid | (1,840) | (1,576) | (1,288) |
| Proceeds from exercise of stock options | 224 | 299 | 421 |
| Excess tax benefits from stock-based compensation | 72 | 127 | 106 |
| Repurchase of common stock | (4,461) | (5,001) | (4,001) |
| Other | (5) | (3) | 0 |
| Net cash (used in) provided by financing activities | (6,689) | 5,006 | (5,694) |
| Effect of exchange rate changes on cash and cash equivalents | 2 | (20) | (6) |
| Net increase (decrease) in cash and cash equivalents | 912 | (22) | (1,608) |
| Cash and cash equivalents at the beginning of the year | 2,459 | 2,481 | |
| Cash and cash equivalents at the end of the year | 3,371 | 2,459 | 2,481 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 5,319 | 5,239 | 4,644 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,475 | 2,092 | 1,931 |
| Stock-based compensation | 222 | 230 | 165 |
| Loss on early extinguishment of debt | 643 | 0 | 521 |
| Deferred income taxes and other noncash items | 153 | (266) | (58) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (243) | (1,594) | (737) |
| Inventories | (742) | (1,141) | (770) |
| Other current assets | 35 | 355 | (383) |
| Other assets | (43) | 2 | 9 |
| Accounts payable and claims and discounts payable | 2,189 | 2,834 | 1,742 |
| Accrued expenses | 59 | 765 | 1,060 |
| Other long-term liabilities | 2 | (104) | 13 |
| Net cash provided by operating activities | 10,069 | 8,412 | 8,137 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2016 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 9, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| Assets: | ||
| Cash and cash equivalents | $ 3,371 | 2,459 |
| Short-term investments | 87 | 88 |
| Accounts receivable, net | 12,164 | 11,888 |
| Inventories | 14,760 | 14,001 |
| Other current assets | 660 | 722 |
| Total current assets | 31,042 | 29,158 |
| Property and equipment, net | 10,175 | 9,855 |
| Goodwill | 38,249 | 38,106 |
| Intangible assets, net | 13,511 | 13,878 |
| Other assets | 1,485 | 1,440 |
| Total assets | 94,462 | 92,437 |
| Liabilities: | ||
| Accounts payable | 7,946 | 7,490 |
| Claims and discounts payable | 9,451 | 7,653 |
| Accrued expenses | 6,937 | 6,829 |
| Short-term debt | 1,874 | 0 |
| Current portion of long-term debt | 42 | 1,197 |
| Total current liabilities | 26,250 | 23,169 |
| Long-term debt | 25,615 | 26,267 |
| Deferred income taxes | 4,214 | 4,217 |
| Other long-term liabilities | 1,549 | 1,542 |
| Commitments and contingencies (Note 11) | 0 | 0 |
| Redeemable noncontrolling interest | 0 | 39 |
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | |
| Common stock, par value $0.01: 3,200 shares authorized, 1,705 shares issued and 1,061 shares outstanding at December 31, 2016 and 1,699 shares issued and 1,101 shares outstanding at December 31, 2015 | 17 | 17 |
| Treasury stock, at cost: 643 shares at December 31, 2016 and 597 shares at December 31, 2015 | (33,452) | (28,886) |
| Shares held in trust: 1 share at December 31, 2016 and 2015 | (31) | (31) |
| Capital surplus | 31,618 | 30,948 |
| Retained earnings | 38,983 | 35,506 |
| Accumulated other comprehensive income (loss) | (305) | (358) |
| Total CVS Health shareholders equity | 36,830 | 37,196 |
| Noncontrolling interest | 4 | 7 |
| Total shareholders equity | 36,834 | 37,203 |
| Total liabilities and shareholders equity | 94,462 | 92,437 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |